These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17434827)

  • 21. [Clinical results and costs due to improved antibiotics policies].
    Gyssens IC; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women's and children's hospital, Singapore.
    Seah XF; Ong YL; Tan SW; Krishnaswamy G; Chong CY; Tan NW; Thoon KC
    Pharmacotherapy; 2014 Nov; 34(11):1141-50. PubMed ID: 25283969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country.
    Sáez-Llorens X; Castrejón de Wong MM; Castaño E; De Suman O; De Morös D; De Atencio I
    Pediatr Infect Dis J; 2000 Mar; 19(3):200-6. PubMed ID: 10749459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversing resistance: The next generation antibacterials.
    Shah NJ
    Indian J Pharmacol; 2015; 47(3):248-55. PubMed ID: 26069360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends and Correlation Between Antimicrobial Resistance and Antibiotics Consumption in a Specialist Children's Hospital from 2016 to 2021.
    Gong W; Tang W; Luo L; Zhang F; Cai C; Zhang J; Wu X; Shang J; Shu X; Wang T; Tu D; Jin Z; Zheng R
    Infect Drug Resist; 2022; 15():5679-5689. PubMed ID: 36193295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of legal antibiotic restrictions on consumption of broad-spectrum beta-lactam antibiotics, glycopeptides and amphotericin B.
    Kurt H; Karabay O; Birengel S; Memikoglu O; Yılmaz Bozkurt G; Yalçı A
    Chemotherapy; 2010; 56(5):359-63. PubMed ID: 20926859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting.
    Gottesman BS; Carmeli Y; Shitrit P; Chowers M
    Clin Infect Dis; 2009 Sep; 49(6):869-75. PubMed ID: 19686074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Implementation of antimicrobial resistance surveillance and antibiotic consumption in an intensive care burn department].
    Messadi AA; Thabet L; Bousselmi K; Oueslati S; Ben Redjeb S
    Tunis Med; 2008 May; 86(5):486-9. PubMed ID: 19469305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance--antibiotic DU90% profiles with bacterial resistance rates: a visual presentation.
    Mimica Matanovic S; Bergman U; Vukovic D; Wettermark B; Vlahovic-Palcevski V
    Int J Antimicrob Agents; 2010 Oct; 36(4):369-73. PubMed ID: 20688486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria.
    Antoniadou A; Kanellakopoulou K; Kanellopoulou M; Polemis M; Koratzanis G; Papademetriou E; Poulakou G; Giannitsioti E; Souli M; Vatopoulos A; Giamarellou H
    Scand J Infect Dis; 2013 Jun; 45(6):438-45. PubMed ID: 23336730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial drug resistance in Taiwan.
    Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S174-8. PubMed ID: 19013350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting.
    Marra AR; de Almeida SM; Correa L; Silva M; Martino MD; Silva CV; Cal RG; Edmond MB; dos Santos OF
    Am J Infect Control; 2009 Apr; 37(3):204-9. PubMed ID: 18986735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of resistance and utilization of fluoroquinolones in a university hospital].
    Vlcek J; Pozlerová E; Lonská V; Kotlár J
    Ceska Slov Farm; 1997 Oct; 46(5):195-8. PubMed ID: 9600142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
    Siddiqui S; Hussein K; Manasia R; Samad A; Salahuddin N; Zafar A; Hoda MQ
    J Pak Med Assoc; 2007 Oct; 57(10):484-7. PubMed ID: 17990421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation and outcomes of a hospital-wide computerised antimicrobial stewardship programme in a large medical centre in Taiwan.
    Chan YY; Lin TY; Huang CT; Deng ST; Wu TL; Leu HS; Chiu CH
    Int J Antimicrob Agents; 2011 Dec; 38(6):486-92. PubMed ID: 21982143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.